| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| LENZ Therapeutics, Inc. | Chief Commercial Officer | Common Stock | 4.73K | $125K | $26.37 | Nov 17, 2025 | Direct |
| LENZ Therapeutics, Inc. | Chief Commercial Officer | Stock Option (right to buy) | 53.2K | Nov 17, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| LENZ | LENZ Therapeutics, Inc. | Nov 17, 2025 | 4 | -$240K | 4 | Nov 19, 2025 | Chief Commercial Officer |
| LENZ | LENZ Therapeutics, Inc. | Apr 9, 2025 | 2 | $2.91K | 4 | Apr 9, 2025 | Chief Commercial Officer |
| LENZ | LENZ Therapeutics, Inc. | Jan 9, 2025 | 1 | $0 | 4 | Jan 13, 2025 | Chief Commercial Officer |
| LENZ | LENZ Therapeutics, Inc. | Dec 16, 2024 | 2 | $6.93K | 4 | Dec 17, 2024 | Chief Commercial Officer |
| LENZ | LENZ Therapeutics, Inc. | Mar 21, 2024 | 4 | $0 | 4 | Mar 25, 2024 | Chief Commercial Officer |
| LENZ | LENZ Therapeutics, Inc. | Mar 21, 2024 | 0 | $0 | 3 | Mar 25, 2024 | Chief Commercial Officer |